Literature DB >> 16930866

Huntington disease as a dual diagnosis disorder: data from the National Research Roster for Huntington disease patients and families.

Jason C Ehret1, Patricia S Day, Ryan Wiegand, Joanne Wojcieszek, R Andrew Chambers.   

Abstract

Although an extensive literature characterizes a linkage between primary mental illnesses and substance use disorders, a paucity of research exists concerning dual diagnosis phenomena in Huntington disease (HD). Data from the National Research Roster on HD suggest that higher levels of alcohol and cigarette use are associated with greater ratings of psychiatric symptoms and a younger age of HD symptom onset, and that progressive alcohol use after HD symptom onset is linked with worsening psychiatric symptom progression. These findings suggest HD entails dual diagnosis phenomena similar to that identified in patients with primary psychiatric disorders.

Entities:  

Mesh:

Year:  2006        PMID: 16930866      PMCID: PMC2877623          DOI: 10.1016/j.drugalcdep.2006.06.009

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  28 in total

1.  Clinical markers of early disease in persons near onset of Huntington's disease.

Authors:  J S Paulsen; H Zhao; J C Stout; R R Brinkman; M Guttman; C A Ross; P Como; C Manning; M R Hayden; I Shoulson
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

Review 2.  Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease.

Authors:  D Joel
Journal:  Mov Disord       Date:  2001-05       Impact factor: 10.338

3.  The distribution of structural neuropathology in pre-clinical Huntington's disease.

Authors:  M J Thieben; A J Duggins; C D Good; L Gomes; N Mahant; F Richards; E McCusker; R S J Frackowiak
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

Review 4.  A neurobiological basis for substance abuse comorbidity in schizophrenia.

Authors:  R A Chambers; J H Krystal; D W Self
Journal:  Biol Psychiatry       Date:  2001-07-15       Impact factor: 13.382

5.  Onset symptoms in 510 patients with Huntington's disease.

Authors:  L Di Maio; F Squitieri; G Napolitano; G Campanella; J A Trofatter; P M Conneally
Journal:  J Med Genet       Date:  1993-04       Impact factor: 6.318

Review 6.  Psychiatric features of Huntington's disease: recent approaches and findings.

Authors:  S E Folstein; M F Folstein
Journal:  Psychiatr Dev       Date:  1983

Review 7.  The epidemiology of Huntington's disease.

Authors:  P S Harper
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

8.  Neuropathological classification of Huntington's disease.

Authors:  J P Vonsattel; R H Myers; T J Stevens; R J Ferrante; E D Bird; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1985-11       Impact factor: 3.685

9.  Progression rate and age at onset are related in autosomal dominant neurologic diseases.

Authors:  R D Currier; J F Jackson; E F Meydrech
Journal:  Neurology       Date:  1982-08       Impact factor: 9.910

10.  Huntington's disease: clinical correlates of disability and progression.

Authors:  N Mahant; E A McCusker; K Byth; S Graham
Journal:  Neurology       Date:  2003-10-28       Impact factor: 9.910

View more
  5 in total

1.  Substance abuse may be a risk factor for earlier onset of Huntington disease.

Authors:  Joanne A Byars; Leigh J Beglinger; David J Moser; Pedro Gonzalez-Alegre; Peg Nopoulos
Journal:  J Neurol       Date:  2012-01-25       Impact factor: 4.849

2.  Substance abuse may hasten motor onset of Huntington disease: Evaluating the Enroll-HD database.

Authors:  Jordan L Schultz; John A Kamholz; David J Moser; Shawna M E Feely; Jane S Paulsen; Peg C Nopoulos
Journal:  Neurology       Date:  2017-02-01       Impact factor: 9.910

3.  An exploration of the experience of Huntington's disease in family dyads: an interpretative phenomenological analysis.

Authors:  Caroline Maxted; Jane Simpson; Stephen Weatherhead
Journal:  J Genet Couns       Date:  2013-11-10       Impact factor: 2.537

Review 4.  Huntington's Chorea-a Rare Neurodegenerative Autosomal Dominant Disease: Insight into Molecular Genetics, Prognosis and Diagnosis.

Authors:  Pratik Talukder; Annapurna Jana; Shrirupa Dhar; Saikat Ghosh
Journal:  Appl Biochem Biotechnol       Date:  2021-07-07       Impact factor: 2.926

5.  Varenicline improves motor and cognitive symptoms in early Huntington's disease.

Authors:  Ailsa L McGregor; Jo Dysart; Malcolm D Tingle; Bruce R Russell; Rob R Kydd; Gregory Finucane
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-19       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.